![]() |
市場調查報告書
商品編碼
1963858
安瓿及泡殼包裝市場-全球產業規模、佔有率、趨勢、機會、預測:依包裝類型、材料、最終用戶、地區及競爭格局分類,2021-2031年Ampoules & Blister Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Packaging Type, By Material, By End User, By Region & Competition, 2021-2031F |
||||||
全球安瓿和泡殼包裝市場預計將從 2025 年的 152.1 億美元成長到 2031 年的 236.7 億美元,複合年成長率為 7.65%。
這些包裝形式作為重要的初級容器系統發揮作用。安瓿瓶是用於儲存液體的密封玻璃或塑膠容器,而泡殼包裝則將單劑量藥物封裝在模製腔體中並用蓋子密封。市場擴張的主要促進因素是慢性病患者數量的增加,他們需要嚴格遵醫囑用藥,以及對無菌、防篡改解決方案的需求不斷成長,以確保產品穩定性。此外,全球監管要求強制執行序列化和防偽通訊協定,也迫使製造商採用這些包裝形式,以確保供應鏈的完整性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 152.1億美元 |
| 市場規模:2031年 | 236.7億美元 |
| 複合年成長率:2026-2031年 | 7.65% |
| 成長最快的細分市場 | 泡殼包裝 |
| 最大的市場 | 北美洲 |
儘管取得了這些積極進展,但鑑於日益嚴格的環境法規,該行業仍面臨嚴峻的挑戰。迫切需要最大限度地減少不可回收廢棄物,這要求從傳統的多層阻隔薄膜向新型包裝材料轉型,而這一轉變會使生產流程更加複雜,並增加營運成本。該產業的經濟重要性依然很高;根據美國軟性包裝協會預測,到2024年,美國醫療和製藥包裝市場的規模將達到61億美元,凸顯了該產業對這些重要包裝形式的高度依賴。
推動全球安瓿和泡殼包裝市場成長的主要因素是全球藥品產量不斷增加以及學名藥消費量的成長。這種基於銷售的成長是為了應對慢性病發病率的上升,同時,市場也需要經濟高效、高通量的解決方案,例如泡殼包裝,以確保患者用藥依從性和產品穩定性。學名藥在維持醫療保健的可及性方面發揮著至關重要的作用。根據美國可及藥品協會(Association for Accessible Medicines)於2025年9月發布的《2025年美國非專利和生物類似藥節省報告》,非專利和生物類似藥將在2024年為美國醫療保健系統節省4670億美元,從而對堅固耐用的初級包裝產生了大規模的需求。同時,市場正從單純追求銷售轉向追求價值,尤其關注用於敏感藥物的專用包裝容器。例如,肖特製藥公司報告稱,到 2025 年,其高附加價值解決方案 (HVS) 的收入佔有率將上升至 57%,這表明該公司正在戰略性地轉向複雜的、高利潤的藥物輸送系統,例如先進的安瓿瓶。
同時,向永續和環保材料的快速轉型正在推動變革,重塑材料選擇和生產流程。監管機構正加大對製藥公司的壓力,要求其減少對環境的影響,鼓勵其從傳統的聚氯乙烯 (PVC) 和鋁結構轉向可回收且能保持阻隔性能的替代品。這種向循環經濟的轉變正在推動單一材料薄膜和生物基聚合物的創新。作為這種轉變的佐證,安姆科 (Amcor) 在其 2025 年 10 月發布的《永續發展報告》中指出,到該會計年度末,該公司已為其 96% 的軟包裝產品系列設計了可回收方案,這表明該行業正在迅速響應生態設計要求。
全球安瓿瓶和泡殼包裝市場面臨的主要障礙是遵守嚴格的環境法規。這些監管壓力阻礙了市場擴張,因為它們要求企業從傳統上提供最佳保護的多層阻隔薄膜過渡到單一材料或可回收的替代品,而這個過渡過程複雜且高成本。這種過渡需要大量的研發工作,以檢驗新型環保材料是否能夠提供敏感醫療產品所需的密封性和穩定性。因此,製造商被迫投入大量資金重新檢驗生產線和改造設備,而這些資金原本可以用於擴大產能和市場佔有率。
嚴格的法律制度給包裝製造商帶來了營運上的不確定性和沈重的行政負擔。大量的新監管要求迫使企業將大量資源投入合規監控,而非創新。根據軟性包裝協會 (FPA) 發布的《2025 年報告》,該協會在 2024 年追蹤了超過 490 項可能影響行業相關人員,尤其關注生產者延伸責任制 (EPR) 和標籤標準。如此集中的立法活動凸顯了法規環境的不穩定性,使長期策略規劃變得更加複雜,並減緩了整體市場的發展動能。
從玻璃安瓿瓶向先進聚合物和塑膠安瓿瓶的轉變正在從根本上改變市場格局,因為這需要克服傳統玻璃容器通用的破損風險和分層問題。製造商擴大採用環烯烴共聚物 (COC) 和環烯烴聚合物 (COP) 材料,這些材料兼具高耐久性和化學惰性,並能防止蛋白質吸附。材料的這種革新使得複雜且高精度的封裝設計成為可能,而這些設計是玻璃難以實現的,同時也提高了填充線的效率。根據格雷斯海默公司於 2025 年 2 月發布的 2024 會計年度年度報告,該公司塑膠設備部門在 2024 會計年度實現了 11.413 億歐元的營收,實現了 8.0% 的內部成長,這主要得益於市場對塑膠容器解決方案的持續需求。
同時,將智慧技術應用於藥物依從性和追蹤正成為一項關鍵趨勢,將傳統的泡殼包裝轉變為智慧數據採集系統。這些智慧包裝解決方案採用嵌入式RFID標籤、近距離場通訊(NFC)和導電油墨電路,透過即時監測藥物取用狀態和存量基準,直接解決患者用藥依從性問題。這些技術能夠提供供應鏈和患者行為的數位可視性,幫助製藥公司減少廢棄物並提高臨床試驗的準確性。根據美國主動與智慧包裝產業協會(AIPIA)2025年9月發布的報導《智慧RFID標籤提升醫療保健的安全性和效率》,Schreiner Medipharm的RFID解決方案迄今已實現了超過3.25億劑注射用急救和麻醉劑的數位追蹤。
The Global Ampoules & Blister Packaging Market is projected to expand from USD 15.21 Billion in 2025 to USD 23.67 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.65%. These packaging formats serve as essential primary containment systems; ampoules provide hermetically sealed glass or plastic vessels for liquid preservation, while blister packs secure unit doses within formed cavities sealed by lidding. Market expansion is largely driven by the increasing prevalence of chronic diseases that require strict medication adherence, alongside the demand for sterile, tamper-evident solutions to ensure product stability. Furthermore, global regulatory requirements enforcing serialization and anti-counterfeiting protocols are compelling manufacturers to adopt these packaging types to guarantee supply chain integrity.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 15.21 Billion |
| Market Size 2031 | USD 23.67 Billion |
| CAGR 2026-2031 | 7.65% |
| Fastest Growing Segment | Blisters |
| Largest Market | North America |
Despite these positive indicators, the industry faces substantial hurdles regarding stringent environmental regulations. The urgent push to minimize non-recyclable waste necessitates a difficult transition from traditional multi-layer barrier films, a shift that complicates manufacturing processes and escalates operational costs. The economic significance of this sector remains high; according to the Flexible Packaging Association, the medical and pharmaceutical packaging segment in the United States reached a valuation of $6.1 billion in 2024, highlighting the industry's crucial dependence on these essential packaging formats.
Market Driver
The primary force accelerating the Global Ampoules & Blister Packaging Market is the escalation of global pharmaceutical production combined with increased generic drug consumption. This volume-based growth addresses the rising incidence of chronic diseases, necessitating cost-efficient, high-throughput solutions like blister packs to ensure patient compliance and product stability. Generics play a vital role in maintaining healthcare accessibility; according to the Association for Accessible Medicines' '2025 U.S. Generic & Biosimilar Medicines Savings Report' from September 2025, generic and biosimilar medicines delivered $467 billion in savings to the U.S. healthcare system in 2024, necessitating massive scales of robust primary packaging. Concurrently, the market is pivoting from pure volume to value, focusing on specialized containment for sensitive drugs. For instance, SCHOTT Pharma reported in 2025 that its High-Value Solutions (HVS) revenue share rose to 57%, indicating a strategic shift toward complex, high-margin drug delivery systems such as advanced ampoules.
In parallel, the rapid move toward sustainable and eco-friendly materials acts as a transformative driver, reshaping material selection and manufacturing workflows. Regulatory authorities are increasing pressure on pharmaceutical firms to lower their environmental footprint, prompting a switch from traditional polyvinyl chloride (PVC) and aluminum structures to recyclable alternatives that maintain barrier protection. This drive for circularity fosters innovation in mono-material films and bio-based polymers. As evidence of this adaptation, Amcor's '2025 Sustainability Report' from October 2025 noted that the company had engineered recycle-ready options for 96% of its flexible packaging portfolio by the fiscal year's end, showcasing the industry's swift response to eco-design mandates.
Market Challenge
A major obstacle facing the Global Ampoules & Blister Packaging Market is the challenge of complying with rigorous environmental regulations. These regulatory pressures impede market expansion by necessitating a complicated and expensive shift from established multi-layer barrier films-which traditionally offer optimal protection-toward mono-material or recyclable substitutes. This transition demands extensive research and development to verify that new eco-friendly materials can provide the necessary hermetic sealing and stability required for sensitive medical products. As a result, manufacturers are forced to direct significant capital expenditure toward re-validating production lines and modifying equipment, diverting funds that might otherwise be used for capacity expansion or market broadening.
The intensity of this legislative landscape generates operational uncertainty and places a heavy administrative burden on packaging converters. The overwhelming volume of new mandates forces companies to dedicate substantial resources to compliance monitoring rather than innovation. According to the Flexible Packaging Association's 2025 report, the organization tracked over 490 legislative bills introduced in 2024 potentially affecting industry members, with a focus on extended producer responsibility and labeling standards. This high concentration of legislative activity highlights a volatile regulatory environment that complicates long-term strategic planning and decelerates the market's overall momentum.
Market Trends
The shift from glass to advanced polymer and plastic ampoules is fundamentally altering the market landscape, driven by the necessity to eliminate breakage risks and delamination issues common with traditional glass formats. Manufacturers are increasingly utilizing cyclic olefin copolymer (COC) and cyclic olefin polymer (COP) materials, which offer exceptional durability and chemical inertness for sensitive biologics while preventing protein adsorption. This material evolution allows for the creation of complex, high-precision containment designs that are difficult to execute with glass, thereby improving filling line efficiency. Highlighting this trend, Gerresheimer's 'Annual Report 2024', released in February 2025, revealed that its Plastics & Devices Division achieved EUR 1,141.3 million in revenue for the 2024 financial year, marking an organic growth of 8.0% fueled by the sustained demand for these plastic containment solutions.
Concurrently, the integration of smart technologies for medication adherence and tracking is emerging as a significant trend, converting standard blister packs into intelligent data-gathering systems. These smart packaging solutions employ embedded RFID tags, Near Field Communication (NFC), and conductive ink circuits to monitor real-time dosage removal and inventory levels, directly addressing patient non-compliance. By offering digital visibility into both the supply chain and patient behavior, these technologies assist pharmaceutical companies in reducing waste and enhancing clinical trial accuracy. According to the Active & Intelligent Packaging Industry Association's September 2025 article, 'Smart RFID-Labels offer more safety and efficiency in the healthcare sector', Schreiner MediPharm's RFID solutions have enabled the digital tracking of over 325 million units of injectable emergency and anesthetic drugs to date.
Report Scope
In this report, the Global Ampoules & Blister Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Ampoules & Blister Packaging Market.
Global Ampoules & Blister Packaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: